Human Papillomavirus-related Carcinoma
📧 Sign up to get email alerts when something new happens for Human Papillomavirus-related Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing RG1-VLP Vaccine to Prevent HPV-related Cancers [Phase 1]
The National Cancer Institute is conducting a Phase 1 trial to evaluate the RG1-VLP vaccine for preventing HPV-related carcinomas, with recr…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years [Phase 2]
Phase 2 clinical trial to evaluate the safety and immunogenicity of a 15-valent HPV recombinant vaccine in Chinese people aged 9-45; current…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: IBRX-042 In Participants With HPV-Associated Tumors [Phase 1]
This clinical trial update covers the Phase 1 study of IBRX-042 in HPV-related carcinoma and notes that the trial is currently active but no…